MDWD Reports $17M Revenue, $54M Cash, $17M 2025 Rev, +$2.2M Adj EBITDA, Phase III EscharEx Advancing, NexoBrid Facility Operational, 2026 Regulatory Approvals Expected
MediWound Ltd. · Now $13.82
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS